On Friday, Marex Group earned an upgrade to its Relative Strength (RS) Rating, from 67 to 71.
When To Sell Stocks To Lock In Profits And Minimize Losses
IBD's unique RS Rating tracks market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price action over the last 52 weeks compares to the rest of the market.
Over 100 years of market history shows that the best-performing stocks often have an RS Rating of at least 80 in the early stages of their moves. See if Marex Group can continue to rebound and clear that threshold.
Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock goes on to form a chart pattern and break out.
Marex Group reported 32% EPS growth in its most recent report. Revenue increased 28%. The next quarterly numbers are expected on or around Aug. 13.
Marex Group earns the No. 17 rank among its peers in the Financial Services-Specialty industry group. CME Group Cl A, IREN and Virtu Financial are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
